# STOCKHOLM 1.0
#=GF ID   Peptidase_C30
#=GF AC   PF05409.17
#=GF DE   Coronavirus endopeptidase C30
#=GF AU   Studholme DJ;0000-0002-3010-6637
#=GF AU   Chuguransky S;0000-0002-0520-0736
#=GF SE   Manual
#=GF GA   25.00 25.00;
#=GF TC   41.10 317.30;
#=GF NC   23.80 20.60;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch -E 1000 --cpu 4 -Z 75585367 HMM pfamseq
#=GF TP   Family
#=GF WK   C30_Endopeptidase
#=GF CL   CL0124
#=GF RN   [1]
#=GF RM   12093723
#=GF RT   Structure of coronavirus main proteinase reveals combination of
#=GF RT   a chymotrypsin fold with an extra alpha-helical domain. 
#=GF RA   Anand K, Palm GJ, Mesters JR, Siddell SG, Ziebuhr J, Hilgenfeld
#=GF RA   R; 
#=GF RL   EMBO J 2002;21:3213-3224.
#=GF RN   [2]
#=GF RM   10725411
#=GF RT   Virus-encoded proteinases and proteolytic processing in the
#=GF RT   Nidovirales. 
#=GF RA   Ziebuhr J, Snijder EJ, Gorbalenya AE; 
#=GF RL   J Gen Virol 2000;81:853-879.
#=GF RN   [3]
#=GF RM   11842254
#=GF RT   Conservation of substrate specificities among coronavirus main
#=GF RT   proteases. 
#=GF RA   Hegyi A, Ziebuhr J; 
#=GF RL   J Gen Virol 2002;83:595-599.
#=GF RN   [4]
#=GF RM   12746549
#=GF RT   Coronavirus main proteinase (3CLpro) structure: basis for design
#=GF RT   of anti-SARS drugs.
#=GF RA   Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R;
#=GF RL   Science. 2003;300:1763-1767.
#=GF RN   [5]
#=GF RM   18094151
#=GF RT   Structures of two coronavirus main proteases: implications for
#=GF RT   substrate binding        and antiviral drug design.
#=GF RA   Xue X, Yu H, Yang H, Xue F, Wu Z, Shen W, Li J, Zhou Z, Ding Y,
#=GF RA   Zhao Q, Zhang XC, Liao M, Bartlam M, Rao Z;
#=GF RL   J Virol. 2008;82:2515-2527.
#=GF RN   [6]
#=GF RM   34580920
#=GF RT   Evolution of the SARS-CoV-2 proteome in three dimensions (3D)
#=GF RT   during the first 6  months of the COVID-19 pandemic.
#=GF RA   Lubin JH, Zardecki C, Dolan EM, Lu C, Shen Z, Dutta S, Westbrook
#=GF RA   JD, Hudson BP, Goodsell DS, Williams JK, Voigt M, Sarma V, Xie
#=GF RA   L, Venkatachalam T, Arnold S, Alfaro Alvarado LH, Catalfano K,
#=GF RA   Khan A, McCarthy E, Staggers S, Tinsley B, Trudeau A, Singh J,
#=GF RA   Whitmore L, Zheng H, Benedek M, Currier J, Dresel M, Duvvuru A,
#=GF RA   Dyszel B, Fingar E, Hennen EM, Kirsch M, Khan AA, Labrie-Cleary
#=GF RA   C, Laporte S, Lenkeit E, Martin K, Orellana M, Ortiz-Alvarez de
#=GF RA   la Campa M, Paredes I, Wheeler B, Rupert A, Sam A, See K, Soto
#=GF RA   Zapata S, Craig PA, Hall BL, Jiang J, Koeppe JR, Mills SA,
#=GF RA   Pikaart MJ, Roberts R, Bromberg Y, Hoyer JS, Duffy S, Tischfield
#=GF RA   J, Ruiz FX, Arnold E, Baum J, Sandberg J, Brannigan G, Khare SD,
#=GF RA   Burley SK;
#=GF RL   Proteins. 2021; [Epub ahead of print]
#=GF DR   INTERPRO; IPR008740;
#=GF DR   MEROPS; C30;
#=GF DR   SCOP; 1lvo; fa;
#=GF DR   SO; 0100021; polypeptide_conserved_region;
#=GF CC   This Coronavirus (CoV) domain, peptidase C30, is also known as
#=GF CC   3C-like proteinase (3CL-pro), or CoV main protease (M-pro)
#=GF CC   domain. CoV M-pro (alsp known as non-structural protein 5, NSP5)
#=GF CC   is a dimer where each subunit is composed of three domains I, II
#=GF CC   and III [1,2,3]. Domains I and II consist of six-stranded
#=GF CC   antiparallel beta barrels and together resemble the architecture
#=GF CC   of chymotrypsin, and of picornaviruses 3C proteinases. The
#=GF CC   substrate-binding site is located in a cleft between these two
#=GF CC   domains. The catalytic site is situated at the centre of the
#=GF CC   cleft. A long loop connects domain II to the C-terminal domain
#=GF CC   (domain III). This latter domain has been implicated in the
#=GF CC   proteolytic activity of M-pro. In the active site of M-pro, Cys
#=GF CC   and His form a catalytic dyad [4,5]. In contrast to serine
#=GF CC   proteinases and other cysteine proteinases, which have a
#=GF CC   catalytic triad, there is no third catalytic residue present
#=GF CC   [6]. This peptidase is involved in viral polyprotein processing
#=GF CC   during replication [2,3,5].
#=GF SQ   6
#=GS R1A_SARS/3269-3559      AC P0C6U8.1
#=GS R1A_CVMA5/3362-3648     AC P0C6V0.1
#=GS R1A_CVH22/2994-3281     AC P0C6U2.1
#=GS R1AB_FIPV/2932-3219     AC Q98VG9.2
#=GS R1A_IBVB/2808-3096      AC P0C6V3.1
#=GS B6VDX7_THCOV/2516-2804  AC B6VDX7.1
R1A_SARS/3269-3559                 GLWLDDTVYCPRHVICTAEDMLNPNYEDLLIRKSNHSFLVQ..AGNVQLRVIGHSMQNCLLRLKVDTSNPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNHTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGKFYGPFVDRQTAQAAGTDTTITLNVLAWLYAAVING.......DRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDI..LGPLSAQTGIAVLDMCAALKELLQNGMNGRTILGSTILEDEFTPFDVVRQCSGVTFQ.GKFKKIVKGTHHW
#=GR R1A_SARS/3269-3559      AS    ............*..................................................................................................................................................................................................................................................................................................
#=GR R1A_SARS/3269-3559      pAS   ......................................................................................................................*........................................................................................................................................................................................
R1A_CVMA5/3362-3648                GLWLDDKVYCPRHVICSSADMTDPDYPNLLCRVTSSDFCVM..SGRMSLTVMSYQMQGCQLVLTVTLQNPNTPKYSFGVVKPGETFTVLAAYNGRPQGAFHVTLRSSHTIKGSFLCGSCGSVGYVLTGDSVRFVYMHQLELSTGCHTGTDFSGNFYGPYRDAQVVQLPVQDYTQTVNVVAWLYAAIFNR.......CNWFVQSDSCSLEEFNVWAMTNGFSSIKADLV....LDALASMTGVTVEQVLAAIKR.LHSGFQGKQILGSCVLEDE.TPSDVYQQLAGVKLQ.SKRTRVIKGTCCW
#=GR R1A_CVMA5/3362-3648     pAS   ............*.........................................................................................................*........................................................................................................................................................................................
R1A_CVH22/2994-3281                GLWLGDIVYCPRHVIASNTTSA.IDYDHEYSIMRLHNFSII..SGTAFLGVVGATMHGVTLKIKVSQTNMHTPRHSFRTLKSGEGFNILACYDGCAQGVFGVNMRTNWTIRGSFINGACGSPGYNLKNGEVEFVYMHQIELGSGSHVGSSFDGVMYGGFEDQPNLQVESANQMLTVNVVAFLYAAILNG.......CTWWLKGEKLFVEHYNEWAQANGFTAMNGEDA....FSILAAKTGVCVERLLHAIQV.LNNGFGGKQILGYSSLNDEFSINEVVKQMFGVNLQSGKTTSMFKSISLF
#=GR R1A_CVH22/2994-3281     pAS   ............*.........................................................................................................*........................................................................................................................................................................................
R1AB_FIPV/2932-3219                GLWLGDEVICPRHVIASDTSRV.INYENELSSVRLHNFSIA..KNNAFLGVVSAKYKGVNLVLKVNQVNPNTPEHKFKSVRPGESFNILACYEGCPGSVYGVNMRSQGTIKGSFIAGTCGSVGYVLENGTLYFVYMHHLELGNGSHVGSNLEGEMYGGYEDQPSMQLEGTNVMSSDNVVAFLYAALING.......ERWFVTNTSMTLESYNAWAKTNSFTEIVSTDA....FNMLAAKTGYSVEKLLECIVR.LNKGFGGRTILSYGSLCDEFTPTEVIRQMYGVNLQSGKVKSIFYPMMTA
#=GR R1AB_FIPV/2932-3219     pAS   ............*.........................................................................................................*........................................................................................................................................................................................
R1A_IBVB/2808-3096                 GLWLGDTIYCPRHVLGKFSG...DQWNDVLNLANNHEFEVTT.QHGVTLNVVSRRLKGAVLILQTAVANAETPKYKFIKANCGDSFTIACAYGGTVVGLYPVTMRSNGTIRASFLAGACGSVGFNIEKGVVNFFYMHHLELPNALHTGTDLMGEFYGGYVDEEVAQRVPPDNLVTNNIVAWLYAAIISVKESSFSLPKW.LESTTVSVDDYNKWAGDNGFTPFSTSTA....ITKLSAITGVDVCKLLRTIMV.KNSQWGGDPILGQYNFEDELTPESVFNQIGGVRLQSS....FVRKATSW
#=GR R1A_IBVB/2808-3096      pAS   ............*.........................................................................................................*........................................................................................................................................................................................
B6VDX7_THCOV/2516-2804             GIWLNNVVYCPRHVFGKFKG...EQWQHIASIADCRDFCVVCPTQGIQLTVQSVKMVGAILQLTVHTNNTATPDYEFVRLTPGSSMTIACAYDGVVRNVYHVVLQTNNLIYASFLNGACGSVGYTLKGKTLCLHYMHHLEFNNQTHGGTDLHGVFYGPYVDEEIAQQQTTFQYYTDNVVAQLYAHLLTVDAS....PRW.LAQAEVSETDFNAWASNNSFANFPCEPANMSYILGLAQTSRVSIGRVLNTIIQ.LTLNRNGSLIMGKPDFECDWTPEMVYNQ.APITLQSG....IVQRTSMW
#=GR B6VDX7_THCOV/2516-2804  pAS   ............*.........................................................................................................*........................................................................................................................................................................................
#=GC seq_cons                      GLWLsDpVYCPRHVIuosss.h..sYpclLshsssHsFsVh..sssspLsVlStpMpGshLhLpVspsNspTP+YcFhplpPG-oFoILAsYsGsspGVYtVsMRoNtTI+GSFLsGuCGSVGYsLcsssVpFsYMHHLELssGsHsGTDLcGpFYGsYhDppssQhtsssphhTsNVVAaLYAAllNs.......s+WaLpssosol--aNtWAtsNuFoshss-sA....lshLAApTGVsVp+lLpsIhp.LssGasG+pILGpssLEDEaTPp-VhpQhuGVsLQSGKhppll+ssspW
